MedGenome Inc. is at the EMBL Conference on Cancer Genomics from 1st to 4th November, 2015
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to professionals working in the field of cancer immunology and immunotherapy. Established in 1984,SITC is a 501(c)(3) not-for-profit organization with a growing constituency of academic, government, industry, clinical and basic scientists, and clinicians from around the world.
Through emphasis on high-caliber scientific meetings, dedication to education and outreach activities, focus on initiatives of major importance in the field, and commitment to collaborations with like-minded domestic and international organizations, government and regulatory agencies, associations and patient advocacy groups,SITC brings together all aspects of the cancer immunology and immunotherapy community.
Enquire
Now 